These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30324476)

  • 21. RECIST for Response (Clinical and Imaging) in Neoadjuvant Clinical Trials in Operable Breast Cancer.
    Semiglazov V
    J Natl Cancer Inst Monogr; 2015 May; 2015(51):21-3. PubMed ID: 26063880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Magnetic Resonance Imaging in Detection of Pathologic Complete Remission in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Meta-analysis.
    Gu YL; Pan SM; Ren J; Yang ZX; Jiang GQ
    Clin Breast Cancer; 2017 Jul; 17(4):245-255. PubMed ID: 28209330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast.
    Drew PJ; Kerin MJ; Mahapatra T; Malone C; Monson JR; Turnbull LW; Fox JN
    Eur J Surg Oncol; 2001 Nov; 27(7):617-20. PubMed ID: 11669587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ASO Author Reflections: Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer.
    Andrianello S; Marchegiani G; Salvia R
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):810-811. PubMed ID: 30374921
    [No Abstract]   [Full Text] [Related]  

  • 25. Change in microcalcifications on mammography after neoadjuvant chemotherapy in breast cancer patients: correlation with tumor response grade and comparison with lesion extent.
    Yim H; Ha T; Kang DK; Park SY; Jung Y; Kim TH
    Acta Radiol; 2019 Feb; 60(2):131-139. PubMed ID: 29764199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ASO Author Reflections: Transoral Robotic Surgery Combined with Neoadjuvant Chemotherapy for Management of Advanced Laryngohypopharyngeal Cancer.
    Park YM; Kim SH
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):894-895. PubMed ID: 30288650
    [No Abstract]   [Full Text] [Related]  

  • 27. Residual Mammographic Microcalcifications and Enhancing Lesions on MRI After Neoadjuvant Systemic Chemotherapy for Locally Advanced Breast Cancer: Correlation with Histopathologic Residual Tumor Size.
    Kim YS; Chang JM; Moon HG; Lee J; Shin SU; Moon WK
    Ann Surg Oncol; 2016 Apr; 23(4):1135-42. PubMed ID: 26628432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ASO Author Reflections: Disparities in Outcome and Surgical Management Following Neoadjuvant Chemotherapy for Breast Cancer.
    Relation T; Oppong BA
    Ann Surg Oncol; 2021 Oct; 28(11):6498-6499. PubMed ID: 33660126
    [No Abstract]   [Full Text] [Related]  

  • 29. Do Calcifications Seen on Mammography After Neoadjuvant Chemotherapy for Breast Cancer Always Need to Be Excised?
    Feliciano Y; Mamtani A; Morrow M; Stempel MM; Patil S; Jochelson MS
    Ann Surg Oncol; 2017 Jun; 24(6):1492-1498. PubMed ID: 28058550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.
    Chagpar AB; Middleton LP; Sahin AA; Dempsey P; Buzdar AU; Mirza AN; Ames FC; Babiera GV; Feig BW; Hunt KK; Kuerer HM; Meric-Bernstam F; Ross MI; Singletary SE
    Ann Surg; 2006 Feb; 243(2):257-64. PubMed ID: 16432360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ASO Author Reflections: Changes in Use of Neoadjuvant Chemotherapy Over Time-Highest Rates of Use Now in Triple-Negative and HER2+ Disease.
    Murphy BL; Boughey JC
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):695-696. PubMed ID: 30465221
    [No Abstract]   [Full Text] [Related]  

  • 32. Changes in findings of mammography, ultrasonography and contrast-enhanced computed tomography of three histological complete responders with primary breast cancer before and after neoadjuvant chemotherapy: case reports.
    Nakamura T; Fukutomi T; Tsuda H; Akashi-Tanaka S; Matsuo K; Shimizu C; Miyakawa K
    Jpn J Clin Oncol; 2000 Oct; 30(10):453-7. PubMed ID: 11185893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of mammography, digital breast tomosynthesis, automated breast ultrasound, magnetic resonance imaging in evaluation of residual tumor after neoadjuvant chemotherapy.
    Park J; Chae EY; Cha JH; Shin HJ; Choi WJ; Choi YW; Kim HH
    Eur J Radiol; 2018 Nov; 108():261-268. PubMed ID: 30396666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ASO Author Reflections: Neoadjuvant Chemotherapy Does Not Affect Short-Term Outcomes After Breast Cancer Surgery.
    Konishi T; Fujiogi M; Tanabe M; Seto Y; Yasunaga H
    Ann Surg Oncol; 2022 May; 29(5):3011-3012. PubMed ID: 34997419
    [No Abstract]   [Full Text] [Related]  

  • 35. ASO Author Reflections: Postmastectomy Radiotherapy for Breast Cancer Patients After Neoadjuvant Chemotherapy, by Molecular Subtype.
    Ma JC; Zhong XR; Luo T; Liu L
    Ann Surg Oncol; 2021 Sep; 28(9):5096-5097. PubMed ID: 33604825
    [No Abstract]   [Full Text] [Related]  

  • 36. ASO Author Reflections: Identifying pCR After Neoadjuvant Chemotherapy: The Key to Treatment De-escalation in Breast Cancer.
    Lim DW; Hong NJL
    Ann Surg Oncol; 2022 Dec; 29(Suppl 3):570-571. PubMed ID: 34435298
    [No Abstract]   [Full Text] [Related]  

  • 37. Magnetic Resonance Imaging after Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate between No Residual Carcinoma and Residual Ductal Carcinoma In Situ in Patients with Triple-Negative Breast Cancer.
    Park S; Yoon JH; Sohn J; Park HS; Moon HJ; Kim MJ; Kim EK; Kim SI; Park BW
    PLoS One; 2016; 11(2):e0149347. PubMed ID: 26866475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Editorial Comment: Evidence Supporting Contrast-Enhanced Mammography (CEM) for Monitoring Neoadjuvant Chemotherapy Response and Showing the Potential of Delayed CEM.
    Woodard S
    AJR Am J Roentgenol; 2022 Dec; 219(6):894. PubMed ID: 35766535
    [No Abstract]   [Full Text] [Related]  

  • 39. ASO Author Reflections: Avoiding Mastectomy: The Benefit of Neoadjuvant Chemotherapy for Large Unifocal Breast Tumors.
    Petruolo O; Barrio AV
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):755-756. PubMed ID: 32444911
    [No Abstract]   [Full Text] [Related]  

  • 40. ASO Author Reflections: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery Patients.
    Newhook TE; Tzeng CD
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):749-750. PubMed ID: 31559543
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.